EAGLE VIEW BEHAVIORAL HEALTH
1. Target Overview & Investment Thesis
EAGLE VIEW BEHAVIORAL HEALTH is a 72-bed under-performing / distressed in SCOTT, IA with $11.2M in net patient revenue and a -24.5% operating margin. The hospital serves a payer mix of 11.0% Medicare, 3.2% Medicaid, and 85.8% commercial.
Thesis: Turnaround. Our ML models identify $831K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.5% to -17.1% (+740bps).
| Net Revenue HCRIS | $11.2M |
| Current EBITDA COMPUTED | $-2.8M |
| Operating Margin COMPUTED | -24.5% |
| Occupancy HCRIS | 36.2% |
| Revenue / Bed COMPUTED | $156K |
| Net-to-Gross HCRIS | 31.5% |
| Distress Probability ML | 52.0% |
2. Market Context & Competitive Position
IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of -24.5% places it below the state median. Among 23 size-comparable peers (36-144 beds), the median margin is -16.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (36-144), prioritizing same-state peers. 23 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| EAGLE VIEW BEHAVIORAL HEALTH (Target) | IA | 72 | $11.2M | -24.5% |
| MERCYONE WATERLOO MEDICAL CENT | IA | 134 | $283.3M | -5.1% |
| BROADLAWNS MEDICAL CENTER | IA | 113 | $169.5M | -37.0% |
| MERCYONE DUBUQUE MEDICAL CENTE | IA | 142 | $152.7M | -25.8% |
| MERCYONE SIOUXLAND MEDICAL CEN | IA | 125 | $148.2M | -40.8% |
| TRINITY REGIONAL MEDICAL CENTE | IA | 44 | $140.4M | -6.8% |
| THE FINLEY HOSPITAL | IA | 66 | $121.7M | 0.1% |
| JENNIE EDMUNDSON MEMORIAL | IA | 127 | $121.6M | -5.7% |
| MERCYONE CLINTON MEDICAL CENTE | IA | 107 | $116.1M | -19.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $831K (740bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $236K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $225K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $224K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $137K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +9bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.8M |
| + RCM Uplift | +$831K |
| Pro Forma EBITDA | $-1.9M |
| Current Margin | -24.5% |
| Pro Forma Margin | -17.1% |
| WC Released (1x) | $431K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-4.2M | $-9.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-4.2M | $-12.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.8M | $-10.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.8M | $-12.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-4.7M | $-12.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-4.7M | $-15.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 52.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 23 hospitals with 36-144 beds
- Same-state prioritization (n=24)
- Comp margins: P25=-24.6% / P50=-16.1% / P75=-5.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.